HomeComparePCH vs JNJ

PCH vs JNJ: Dividend Comparison 2026

PCH yields 4.31% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCH wins by $14.6K in total portfolio value
10 years
PCH
PCH
● Live price
4.31%
Share price
$41.73
Annual div
$1.80
5Y div CAGR
12.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.7K
Annual income
$2,362.25
Full PCH calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PCH vs JNJ

📍 PCH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCHJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCH + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCH pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCH
Annual income on $10K today (after 15% tax)
$366.64/yr
After 10yr DRIP, annual income (after tax)
$2,007.91/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, PCH beats the other by $1,304.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCH + JNJ for your $10,000?

PCH: 50%JNJ: 50%
100% JNJ50/50100% PCH
Portfolio after 10yr
$27.3K
Annual income
$1,595.01/yr
Blended yield
5.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PCH
Analyst Ratings
4
Buy
6
Hold
3
Sell
Consensus: Hold
Price Target
$51.00
+22.2% upside vs current
Range: $45.00 — $57.00
Altman Z
1.8
Piotroski
8/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCH buys
0
JNJ buys
0
No recent congressional trades found for PCH or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCHJNJ
Forward yield4.31%3.36%
Annual dividend / share$1.80$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR12.8%5.8%
Portfolio after 10y$34.7K$20.0K
Annual income after 10y$2,362.25$827.78
Total dividends collected$11.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$51.00$228.73

Year-by-year: PCH vs JNJ ($10,000, DRIP)

YearPCH PortfolioPCH Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,187$486.56$10,676$355.77+$511.00PCH
2$12,543$573.79$11,407$389.39+$1.1KPCH
3$14,100$678.27$12,198$426.53+$1.9KPCH
4$15,890$803.75$13,056$467.62+$2.8KPCH
5$17,958$954.93$13,987$513.12+$4.0KPCH
6$20,352$1,137.65$14,998$563.56+$5.4KPCH
7$23,136$1,359.25$16,098$619.52+$7.0KPCH
8$26,385$1,628.94$17,295$681.69+$9.1KPCH
9$30,190$1,958.35$18,599$750.82+$11.6KPCH
10$34,666$2,362.25$20,022$827.78+$14.6KPCH

PCH vs JNJ: Complete Analysis 2026

PCHStock

PotlatchDeltic (NASDAQ:PCH) is a leading Real Estate Investment Trust (REIT) that owns 1.8 million acres of timberlands in Alabama, Arkansas, Idaho, Louisiana, Minnesota and Mississippi. Through its taxable REIT subsidiary, the company also operates six sawmills, an industrial-grade plywood mill, a residential and commercial real estate development business and a rural timberland sales program. PotlatchDeltic, a leader in sustainable forest management, is committed to environmental and social responsibility and to responsible governance.

Full PCH Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PCH vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCH vs SCHDPCH vs JEPIPCH vs OPCH vs KOPCH vs MAINPCH vs ABBVPCH vs MRKPCH vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.